Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota

Clinical Gastroenterology and Hepatology

Volumn 14, Issue 1, 2016, Pages 65-70

  Yadav, Siddhant ^a   Singh, Siddharth ^a   Edakkanambeth Varayil, Jithinraj ^a   Harmsen, W Scott ^a   Zinsmeister, Alan R ^a   Tremaine, William J ^a   Davis, Mark Denis P ^a   Wetter, David A ^a   Colombel, Jean Frederic ^b   Loftus, Edward V ^a  

^a MAYO CLINIC   (United States)

^b Division of Gastroenterology and Hepatology   (United States)

Author keywords

Acne inversa; Crohn's disease; Epidemiology; Hidradenitis suppurativa; Inflammatory bowel disease; Risk factor; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANUS DISEASE; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COLON RESECTION; COMPARATIVE STUDY; CONTROLLED STUDY; CROHN DISEASE; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE PREDISPOSITION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; HURLEY STAGE; ILEOANAL ANASTOMOSIS; INCIDENCE; INFLAMMATORY BOWEL DISEASE; OBESITY; PERIANAL DISEASE; PHENOTYPE; POPULATION RESEARCH; PREVALENCE; RISK ASSESSMENT; SEX DIFFERENCE; SKIN BIOPSY; SKIN SURGERY; SMOKING; SUPPURATIVE HIDRADENITIS; TREND STUDY; ULCERATIVE COLITIS; UNITED STATES; ADOLESCENT; ADULT; COMPLICATION; FEMALE; HIDRADENITIS SUPPURATIVA; MALE; MIDDLE AGED; MINNESOTA; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HIDRADENITIS SUPPURATIVA; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MINNESOTA; RISK ASSESSMENT; SEX FACTORS; YOUNG ADULT;

EID: 84958139292     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.04.173     Document Type: Article

References (17)

1. Jemec G.B. Clinical practice. Hidradenitis suppurativa. N Engl J Med 2012, 366:158-164.
2. Revuz J.E., Canoui-Poitrine F., Wolkenstein P., et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 2008, 59:596-601.
3. Shahi V., Alikhan A., Vazquez B.G., et al. Prevalence of hidradenitis suppurativa: a population-based study in Olmsted County, Minnesota. Dermatology 2014, 229:154-158.
4. Matusiak L., Bieniek A., Szepietowski J.C. Increased serum tumour necrosis factor-alpha in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-alpha agents?. Acta Derm Venereol 2009, 89:601-603.
5. Schlapbach C., Hanni T., Yawalkar N., et al. Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa. J Am Acad Dermatol 2011, 65:790-798.
6. van der Zee H.H., de Winter K., van der Woude C.J., et al. The prevalence of hidradenitis suppurativa in 1093 patients with inflammatory bowel disease. Br J Dermatol 2014, 171:673-675.
7. van der Zee H.H., van der Woude C.J., Florencia E.F., et al. Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study. Br J Dermatol 2010, 162:195-197.
8. Vazquez B.G., Alikhan A., Weaver A.L., et al. Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol 2013, 133:97-103.
9. Rocca W.A., Yawn B.P., St Sauver J.L., et al. History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc 2012, 87:1202-1213.
10. US Census Bureau. United States Census Bureau quick facts. 2014. Available at Accessed: July 4, 2014. http://quickfacts.census.gov/qfd/states/27/27109.html.
11. St Sauver J.L., Grossardt B.R., Yawn B.P., et al. Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol 2012, 41:1614-1624.
12. St Sauver J.L., Grossardt B.R., Yawn B.P., et al. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol 2011, 173:1059-1068.
13. Silverberg M.S., Satsangi J., Ahmad T., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl A):5A-36A.
14. Alikhan A., Lynch P.J., Eisen D.B. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol 2009, 60:539-561.
15. Hurley H. Dermatologic surgery: principles and practice 1996, Marcel Dekker, New York.
16. Lavogiez C., Delaporte E., Darras-Vercambre S., et al. Clinicopathological study of 13 cases of squamous cell carcinoma complicating hidradenitis suppurativa. Dermatology 2010, 220:147-153.
17. Jemec G.B., Heidenheim M., Nielsen N.H. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol 1996, 35:191-194.